Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Weight cycling is a pattern in which individuals repeatedly lose and regain body weight. Researchers have found in a new ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

as an add-on to standard care for the treatment of adults with stage 3 and 4 CKD associated with type 2 diabetes. Bayer has made digital health a core part of its offering to patients, alongside ...

Body weight cycling in type 1 diabetes is associated with increased risk of chronic kidney disease. Maintaining stable weight ...

A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, race, and albuminuria.

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

kidney failure and death from cardiovascular events in patients with type 2 diabetes and chronic kidney disease. The agency cited findings from a late-stage trial by Novo Nordisk, which reported ...